144 related articles for article (PubMed ID: 20056792)
1. Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration.
Grote K; Schuett H; Salguero G; Grothusen C; Jagielska J; Drexler H; Mühlradt PF; Schieffer B
Blood; 2010 Mar; 115(12):2543-52. PubMed ID: 20056792
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells.
Schuett J; Schuett H; Oberoi R; Koch AK; Pretzer S; Luchtefeld M; Schieffer B; Grote K
FASEB J; 2017 Jun; 31(6):2612-2624. PubMed ID: 28274989
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2/6-dependent stimulation of mesenchymal stem cells promotes angiogenesis by paracrine factors.
Grote K; Petri M; Liu C; Jehn P; Spalthoff S; Kokemüller H; Luchtefeld M; Tschernig T; Krettek C; Haasper C; Jagodzinski M
Eur Cell Mater; 2013 Sep; 26():66-79; discussion 79. PubMed ID: 24027020
[TBL] [Abstract][Full Text] [Related]
4. The Lipopeptide MALP-2 Promotes Collateral Growth.
Troidl K; Schubert C; Vlacil AK; Chennupati R; Koch S; Schütt J; Oberoi R; Schaper W; Schmitz-Rixen T; Schieffer B; Grote K
Cells; 2020 Apr; 9(4):. PubMed ID: 32316253
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
Schill T; Schön MP; Pletz N; Emmert S; Schön M
Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
[TBL] [Abstract][Full Text] [Related]
7. Selective JAK/STAT3 signalling regulates transcription of colony stimulating factor-2 and -3 in Concanavalin-A-activated mesenchymal stromal cells.
Zgheib A; Pelletier-Bonnier É; Levros LC; Annabi B
Cytokine; 2013 Aug; 63(2):187-93. PubMed ID: 23688618
[TBL] [Abstract][Full Text] [Related]
8. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
[TBL] [Abstract][Full Text] [Related]
10. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
Downer EJ; Johnston DG; Lynch MA
Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
[TBL] [Abstract][Full Text] [Related]
11. TLR2 agonist Pam3CSK4 enhances the antibacterial functions of GM-CSF induced neutrophils to methicillin-resistant Staphylococcus aureus.
Chen Y; Lu S; Zhang Y; Yu J; Deng L; Chen H; Zhang Y; Zhou N; Yuan K; Yu L; Xiong Z; Gui X; Yu Y; Min W
Microb Pathog; 2019 May; 130():204-212. PubMed ID: 30885749
[TBL] [Abstract][Full Text] [Related]
12. Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2.
Sawahata R; Shime H; Yamazaki S; Inoue N; Akazawa T; Fujimoto Y; Fukase K; Matsumoto M; Seya T
Microbes Infect; 2011 Apr; 13(4):350-8. PubMed ID: 21172450
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis.
Saber T; Veale DJ; Balogh E; McCormick J; NicAnUltaigh S; Connolly M; Fearon U
PLoS One; 2011; 6(8):e23540. PubMed ID: 21858161
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated Src and Janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells.
Zgheib A; Lamy S; Annabi B
J Biol Chem; 2013 May; 288(19):13378-86. PubMed ID: 23548906
[TBL] [Abstract][Full Text] [Related]
15. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA
J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.
Reppe K; Tschernig T; Lührmann A; van Laak V; Grote K; Zemlin MV; Gutbier B; Müller HC; Kursar M; Schütte H; Rosseau S; Pabst R; Suttorp N; Witzenrath M
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):474-81. PubMed ID: 18931326
[TBL] [Abstract][Full Text] [Related]
17. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4.
Bozinovski S; Jones J; Beavitt SJ; Cook AD; Hamilton JA; Anderson GP
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L877-85. PubMed ID: 14617520
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 2 in promoting angiogenesis after acute ischemic injury.
Xu Y; Zhou Y; Lin H; Hu H; Wang Y; Xu G
Int J Mol Med; 2013 Mar; 31(3):555-60. PubMed ID: 23314218
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress in perivascular adipose tissue promotes destabilization of atherosclerotic plaque by regulating GM-CSF paracrine.
Ying R; Li SW; Chen JY; Zhang HF; Yang Y; Gu ZJ; Chen YX; Wang JF
J Transl Med; 2018 Apr; 16(1):105. PubMed ID: 29669585
[TBL] [Abstract][Full Text] [Related]
20. Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment.
Yan WL; Wu CC; Shen KY; Liu SJ
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
